SS-SWT and SI-CNN: An Atrial Fibrillation Detection Framework for Time-Frequency ECG Signal.

J Healthc Eng

Cooperative Innovation Center of Internet Healthcare, Zhengzhou University, Zhengzhou 450001, China.

Published: May 2021


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Atrial fibrillation is the most common arrhythmia and is associated with high morbidity and mortality from stroke, heart failure, myocardial infarction, and cerebral thrombosis. Effective and rapid detection of atrial fibrillation is critical to reducing morbidity and mortality in patients. Screening atrial fibrillation quickly and efficiently remains a challenging task. In this paper, we propose SS-SWT and SI-CNN: an atrial fibrillation detection framework for the time-frequency ECG signal. First, specific-scale stationary wavelet transform (SS-SWT) is used to decompose a 5-s ECG signal into 8 scales. We select specific scales of coefficients as valid time-frequency features and abandon the other coefficients. The selected coefficients are fed to the scale-independent convolutional neural network (SI-CNN) as a two-dimensional (2D) matrix. In SI-CNN, a convolution kernel specifically for the time-frequency characteristics of ECG signals is designed. During the convolution process, the independence between each scale of coefficient is preserved, and the time domain and the frequency domain characteristics of the ECG signal are effectively extracted, and finally the atrial fibrillation signal is quickly and accurately identified. In this study, experiments are performed using the MIT-BIH AFDB data in 5-s data segments. We achieve 99.03% sensitivity, 99.35% specificity, and 99.23% overall accuracy. The SS-SWT and SI-CNN we propose simplify the feature extraction step, effectively extracts the features of ECG, and reduces the feature redundancy that may be caused by wavelet transform. The results shows that the method can effectively detect atrial fibrillation signals and has potential in clinical application.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251457PMC
http://dx.doi.org/10.1155/2020/7526825DOI Listing

Publication Analysis

Top Keywords

atrial fibrillation
28
ecg signal
16
ss-swt si-cnn
12
si-cnn atrial
8
fibrillation detection
8
detection framework
8
framework time-frequency
8
time-frequency ecg
8
morbidity mortality
8
wavelet transform
8

Similar Publications

Development and external validation of a clinical prediction model for new-onset atrial fibrillation in intensive care: a multicentre, retrospective cohort study.

Lancet Digit Health

September 2025

Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK; NIHR Biomedical Research Centre, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Background: New-onset atrial fibrillation, a condition associated with adverse outcomes in the short and long term, is common in patients admitted to intensive care units (ICUs). Identifying patients at high risk could inform trials of preventive interventions and help to target such interventions. We aimed to develop and externally validate a prediction model for new-onset atrial fibrillation in patients admitted to ICUs.

View Article and Find Full Text PDF

Objective: The impact of off-label underdosing of direct oral anticoagulants (DOACs) on clinical outcomes in patients with atrial fibrillation (AF) and stable coronary artery disease (CAD) remains unclear.

Methods: The EPIC-CAD trial (Edoxaban vs Edoxaban with antiPlatelet agent In patients with atrial fibrillation and Chronic stable Coronary Artery Disease) randomised patients with AF and stable CAD to receive either edoxaban monotherapy or dual antithrombotic therapy (edoxaban plus single antiplatelet agent). Off-label underdosing was defined as low-dose edoxaban (30 mg once daily) without standard criteria for dose reduction.

View Article and Find Full Text PDF

Background: Atrial fibrillation (AF) is the most common arrhythmia in adults, with incidence increasing with age. Cognitive impairment (CoI) and dementia share risk factors with AF. Meta-analyses indicate that AF increases the risk of CoI by 2.

View Article and Find Full Text PDF

Objective: Societal guidelines recommend vitamin K antagonists (VKAs) for atrial fibrillation patients with recent biological valve implantation, but the safety and efficacy of direct oral anticoagulants (DOACs) in this setting remain uncertain, especially in the early postoperative period. This substudy of the Left Atrial Appendage Occlusion Study (LAAOS) III trial aimed to compare thromboembolic and bleeding outcomes in patients discharged on VKAs versus DOACs after bioprosthesis implantation or mitral valve repair.

Methods: A total of 2,645 patients were included, with 461 discharged on DOACs and 2184 on VKAs.

View Article and Find Full Text PDF